Historial de carrera de René Muttenzer
Antiguos cargos conocidos de René Muttenzer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACINO HOLDING AG | Director/Miembro de la Junta | 17/11/2009 | 31/03/2012 |
| NOVARTIS AG | Corporate Officer/Principal | - | - |
Posbelduf Biotech AG
 Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Director/Miembro de la Junta | 03/03/2011 | - |
| SPEXIS AG | Director/Miembro de la Junta | 17/11/2009 | - |
Formación de René Muttenzer.
| University of Basel | Graduate Degree |
Estadísticas
Internacional
| Suiza | 6 |
Operativa
| Director/Board Member | 3 |
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SPEXIS AG | Health Technology |
| NOVARTIS AG | Health Technology |
| Empresas privadas | 2 |
|---|---|
Acino International AG
 Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Posbelduf Biotech AG
Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- René Muttenzer
- Experiencia
